Status:
RECRUITING
Locally Optimised Contouring With AI Technology for Radiotherapy
Lead Sponsor:
Royal North Shore Hospital
Conditions:
Contouring
Segmentation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
LOCATOR is a multicentre phase II randomised clinical trial that is looking at the process of contouring in radiation treatment for breast cancer patients. This study looks at whether contouring aided...
Detailed Description
LOCATOR is a multicentre phase II non-inferiority randomised controlled trial looking at comparing AI assisted contours (with in-house LOCATOR software) against fully manual contouring in breast cance...
Eligibility Criteria
Inclusion
- 18 years and older who are planned for primary breast malignancy
- ECOG performance 0-2
- Ability to understand and willingness to sign a written informed consent document
- The target volume must be able to be objectively reviewed by current published national or international clinical guidelines
Exclusion
- Patients under 18 years of age
- Patients unable to understand consent documents
Key Trial Info
Start Date :
February 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
444 Patients enrolled
Trial Details
Trial ID
NCT06546592
Start Date
February 11 2025
End Date
April 30 2030
Last Update
March 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Cancer Centre Dubbo
Dubbo, New South Wales, Australia, 2830
2
Central West Cancer Centre
Orange, New South Wales, Australia, 2800
3
Department of Radiation Oncology, Royal North Shore Hospital
St Leonards, New South Wales, Australia, 2065